This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX Europe

Launch Offer Ends ..

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Life Science Fundraising & Investment
25-26 March 2026Lisbon Congress Centre, Lisbon, Portugal
Life Science Fundraising & Investment
25-26 March 2026,
Lisbon Congress Centre, Lisbon, Portugal

Navigate Biotech Financing: Secure Capital & Drive Growth

Access to Capital: Connect with active biotechnology investors
Strategic Partnerships: Build growth-driving relationships
Expert Knowledge: Gain transformative insights

"LSX has evolved into a trusted partnership which helps us connect with innovative and exciting life science companies"
- Senior Director-Business Development Strategic Operations and Intelligence, Lilly

What is Biotech Leaders?

Join Europe's premier biotech summit connecting visionary leaders, strategic investors, and pharmaceutical executives driving life sciences innovation.

Strategic Capital & Partnership Opportunities - Access targeted insights across oncology, rare diseases, and breakthrough therapeutic platforms while connecting with decision-makers from leading venture funds and pharmaceutical companies.

Accelerating European Success - Experience expert-led sessions and purposeful networking that drives meaningful partnerships across Europe's thriving biotech ecosystem.

Join us to 'Connect with Purpose'.

Biotech Leaders at LSX Europe

Biotechnology innovation, partnerships & investment

Three strategic tracks covering the biotech journey from lab to market.

Early Innovation and Technology Translation

Global Innovation Hotspots - Explore emerging biotech hubs and international collaboration opportunities driving breakthrough discoveries

Lab to Launch Strategies - Navigate critical steps for de-risking academic science, university tech transfer, and IP management

Platform vs. Single Asset Development - Strategic decisions for academic spinouts choosing between comprehensive platforms or focused biotechs

Rare Disease vs. Broad Indications - Evaluate niche opportunities with streamlined regulatory pathways versus larger market potential

Capital Markets and Investment Strategies

Smart Money Allocation - Discover where leading VCs and crossover funds are investing in 2026's selective market environment

Private vs. Public Financing - Understand the shift toward private funding and strategies for attracting venture capital

Early-Stage VC Success - Learn winning pitch strategies, term sheet negotiations, and common fundraising pitfalls

Southern Europe Investment - Explore emerging opportunities in Portugal, Italy, Spain, and France's growing biotech ecosystems

Market Opportunities and Commercialisation

Oncology's Next Frontier - Examine future opportunities beyond checkpoint inhibitors, including ADCs, T-cell engagers, and personalised therapies

Early Commercial Strategy - Embed market insights into R&D decisions and gather feedback from payers, physicians, and patients

Commercial Pitch Excellence - Master the art of communicating commercial potential to investors and strategic partners

Value Creation Strategies - Build sustainable commercial foundations for long-term biotech success

Snapshot of our 2025 attendees

Medtronic

A unique opportunity for companies, big and small.

Ways to Attend

Attend LSX Europe

Attend as a delegate

  • Hear from industry leaders
  • Connect through one-to-one partnering
  • Access case studies and discuss strategy
Speak at LSX Europe

Present your company

  • Increase your visibility
  • Showcase your innovations
  • Attract new investors
Investors at LSX Europe

Join as an investor

  • Access new investment oppertunites
  • Find new opportunities for syndication
  • Understand the latest developments